Skip to content

免疫生物

US · IBRX #1397 按市值排名 上市于 1970
9.18 -0.82 -8.20%
实时 - 追踪5344个代码 - 心跳于224秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了2家。
  • 机构持股总比例下降了0.3个百分点。

机构持股

机构持股比例
53.00% -0.32pp
机构数量
443 -2
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Individual/Insider27.90%
VC/PE Fund24.44%
Mutual Fund13.85%
Private Company9.56%
Hedge Fund3.65%
Public Company1.21%
Government Pension Fund0.12%
Family Office/Trust0.11%
Other19.11%

主要股东 截至 2026-07-31

Patrick Soon-Shiong 27.50% · 291.46M 股
California Capital Equity, LLC 24.44% · 259.00M 股
NantWorks, LLC 9.30% · 98.54M 股
BlackRock 3.22% · 34.08M 股
State Street Global Advisors 2.02% · 21.40M 股
Vanguard Capital Management, LLC 1.71% · 18.10M 股
Vanguard Portfolio Management, LLC 1.69% · 17.86M 股
D. E. Shaw & Co., L.P. 1.09% · 11.55M 股
Two Sigma Investments, LP 1.05% · 11.10M 股
Geode Capital Management, LLC 0.93% · 9.85M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 23次买入 · 27次卖出

姓名职务持股比例
Patrick Soon-Shiong Executive Chairman of the Board, Global Chief Scientific & Medical Officer 27.50%
California Capital Equity, LLC -- 24.44%
Barry Simon Chief Corporate Affairs Officer & Director 0.26%
Richard Adcock Chief Executive Officer 0.05%
David Sachs CFO, Principal Financial Officer & Principal Accounting Officer 0.03%
Michael Blaszyk Independent Director 0.03%
Cheryl Cohen Lead Independent Director 0.01%
Regan Lauer Chief Accounting Officer 0.01%
John Brennan Independent Director 0.00%
Wesley Clark Independent Director 0.00%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-10-04 Barry Simon Chief Corporate Affairs Officer & Director Intent to Sell (Form 144) -560,000 $13.67
2026-07-01 Cheryl Cohen Lead Independent Director Automatic Disposition -75,231 $9.50
2026-07-01 Cheryl Cohen Lead Independent Director Derivative Exercise and Sale -55,979 $2.98–9.50
2026-06-30 Christobel Selecky Independent Director Derivative Exercise and Sale -159,478 $2.98–9.02
2026-06-29 Christobel Selecky Independent Director Derivative Exercise and Sale -96,722 $2.84–9.01
2026-06-29 Christobel Selecky Independent Director Intent to Sell (Form 144) -1,000 $8.77
2026-06-28 Christobel Selecky Independent Director Intent to Sell (Form 144) -95,722 $8.71
2026-06-23 Barry Simon Chief Corporate Affairs Officer & Director Automatic Disposition -25,000 $7.88
2026-06-08 Christobel Selecky Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-08 Wesley Clark Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-08 Bruce Wendel Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-08 Michael Blaszyk Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-08 Cheryl Cohen Lead Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-08 Linda Maxwell Independent Director Other Derivative Acquisition +65,600 $7.25
2026-06-03 Barry Simon Chief Corporate Affairs Officer & Director Automatic Disposition -23,033 $7.18
2026-03-30 California Capital Equity, LLC -- Derivative Exercise and Retained +4,606,596 $5.43
2026-02-23 Barry Simon Chief Corporate Affairs Officer & Director Automatic Disposition -75,000 $12.01
2026-02-22 Christobel Selecky Independent Director Derivative Exercise and Sale -25,000 $2.98–10.00
2026-02-22 Barry Simon Chief Corporate Affairs Officer & Director Automatic Disposition -165,783 $9.25–10.25
2026-02-22 Barry Simon Chief Corporate Affairs Officer & Director Derivative Exercise and Sale -15,243 $8.70–10.25

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:10 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

免疫生物 讨论区 0 条评论

发表评论